Overview


According to FutureWise analysis the market for Proteomics in 2023 is US$ 36.8 billion, and is expected to reach US$ 111.17 billion by 2031 at a CAGR of 14.80%.

The study of the functions and structure of proteins used in drug diagnosis, treatment and discovery of diseases. A proteome is unstable as it is different from cell to cell It is used for the evaluation of the protein production rate, protein interaction, proteins involvement in pathways of the metabolic system, and protein modification. The usage of structural proteomics in identifying the complex protein structure, whereas the functional proteomics is utilized for protein??rotein characteristic interactions in order to demonstrate the functions of the protein.

Proteomics finds in-deep applications in identifying markers for disease diagnosis and drug development and discovery of personalized medicines, which have accelerated the global market in recent years. With growing awareness pertaining to the advantages of personalized medicines, government organizations and companies have increased their expenditure of research and development on developing proteomics.

The global market is predicted to proliferate at a substantial rate over the forecast period, due to personalized medicines getting increasingly popular, soaring expenditure on the research and development and advancements in technology related to proteomics. Moreover, a rise in the availability and awareness of proteomics instruments in developing as well as developed market escalates the market augmentation. Nonetheless, high proteomics component costs and a lack of skilled healthcare professionals in the global proteomics industry hamper the overall market growth. Conversely, profitable opportunities pertaining to the identification of biomarkers and developing mass proteomics based on spectrometry are predicted to offer numerous opportunities for growth to the key players.

The analysis of the global proteomics market size is performed using the component vertical in the report. The component segment accounted for the largest global proteomics market share in 2018, and it is projected to maintain its dominance over the forecast period due to reagents being an integral part of the components of proteomics. The reagents are utilized as a binding material and precursor of chemical reactions during protein structure characterization and analysis. Furthermore, fundamental protocols of proteomics need reagents, which is why this segment is anticipated to occupy the largest market share in the component segment throughout the forecast period.

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Bruker Corporation
  • Danaher Corporation
  • GE Healthcare
  • Luminex Corporation
  • PerkinElmer Inc.
  • Waters Corporation
  • Illumina, Inc.
  • Eurofins Scientific
  • QIAGEN Bioinformatics
  • Creative Proteomics
  • Promega Corporation
  • Sengenics
  • Biomax Informatics AG
  • MS Bioworks LLC
  • WuXi NextCODE
  • Fios Genomics Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Bruker Corporation announced a wide line up of products of mass spectrometry and workflows at the American Society for Mass Spectrometry conference in June 2018. Similarly, ThermoFisher Scientific, Inc. announced iXR Raman Spectrometer in March 2017. This product was manufactured for accurate and rapid structural and chemical analysis. Moreover, Waters Corp. initiated the BioAccord System in January 2019, which is a solution of liquid chromatography-mass spectrometry (LC-MS) that is predicted to extend availability to time-of-flight, high-resolution capabilities of mass spectrometry to more scientists. A considerable rise has been showcased in the collaborations and acquisitions in the global market.
Proteomics

By Instrumentation Technology

  • Spectroscopy
    • Mass Spectroscopy
    • NMR Spectroscopy
    • CD Spectroscopy
  • Chromatography
    • HPLC
    • Ion Chromatography
    • Affinity Chromatography
    • Supercritical Fluid Chromatography
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary Electrophoresis
  • Protein Microarrays
    • Biochips
      • Lab-on-Chips
      • Protein Chips
    • Microarray Instruments
      • Integrated Systems
      • Microarray Scanners
      • Arrayers
  • X – Ray Crystallography
  • Surface Plasmon Resonance
  • Protein Fractionation

By Reagent

  • Immunoassay Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Protein Microarray Reagents
  • X – Ray Crystallography Reagents
  • Electrophoresis Reagents
  • Protein Fractionation Reagents

By Software & Service

  • Core Proteomics Services
    • Protein Identification Services
    • Protein Characterization Services
    • Quantitative Proteomic Services
    • Protein Purification Services
    • Protein Sequencing Services
    • Custom Assay Services
  • Bioinformatics Software & Services
    • Bioinformatics Software
    • Bioinformatics Tools
    • Bioinformatics Databases

By Application

  • Clinical Diagnostics
    • Cancer
    • Infectious Diseases
    • Diabetes
    • Neurological Disorders
    • Immune Diseases
    • Cardiovascular Diseases
    • Other Clinical Diagnostic Applications
  • Drug Discovery
    • Target Discovery
    • Lead Identification
    • Lead Optimization
    • Preclinical Studies
  • Other Application

By End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Academic Research Laboratories
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Proteomics Market By Instrumentation Technology, By Reagent, By Software & Service, By Application, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Proteomics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Proteomics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Proteomics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Proteomics Market, By Instrumentation Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Spectroscopy
         1.1. Mass Spectroscopy
         1.2. NMR Spectroscopy
         1.3. CD Spectroscopy
        2. Chromatography
         2.1. HPLC
         2.2. Ion Chromatography
         2.3. Affinity Chromatography
         2.4. Supercritical Fluid Chromatography
        3. Electrophoresis
         3.1. Gel Electrophoresis
         3.2. Capillary Electrophoresis
        4. Protein Microarrays
         4.1. Biochips
          4.1.1. Lab-on-Chips
          4.1.2. Protein Chips
         4.2. Microarray Instruments
          4.2.1. Integrated Systems
          4.2.2. Microarray Scanners
          4.2.3. Arrayers
        5. X – Ray Crystallography
        6. Surface Plasmon Resonance
        7. Protein Fractionation

  • 8.   Proteomics Market, By Reagent Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Immunoassay Reagents
        2. Spectroscopy Reagents
        3. Chromatography Reagents
        4. Protein Microarray Reagents
        5. X – Ray Crystallography Reagents
        6. Electrophoresis Reagents
        7. Protein Fractionation Reagents

  • 9.   Proteomics Market, By Software Service Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Core Proteomics Services
         1.1. Protein Identification Services
         1.2. Protein Characterization Services
         1.3. Quantitative Proteomic Services
         1.4. Protein Purification Services
         1.5. Protein Sequencing Services
         1.6. Custom Assay Services
        2. Bioinformatics Software & Services
         2.1. Bioinformatics Software
         2.2. Bioinformatics Tools
         2.3. Bioinformatics Databases

  • 10.   Proteomics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Clinical Diagnostics
         1.1. Cancer
         1.2. Infectious Diseases
         1.3. Diabetes
         1.4. Neurological Disorders
         1.5. Immune Diseases
         1.6. Cardiovascular Diseases
         1.7. Other Clinical Diagnostic Applications
        2. Drug Discovery
         2.1. Target Discovery
         2.2. Lead Identification
         2.3. Lead Optimization
         2.4. Preclinical Studies
        3. Other Application

  • 11.   Proteomics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Clinical Laboratories
        3. Pharmaceutical Companies
        4. Academic Research Laboratories
        5. Other End Users

  • 12.   North America Proteomics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Proteomics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Proteomics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Proteomics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bio-Rad Laboratories, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck KGaA
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Agilent Technologies, Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bruker Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Danaher Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. GE Healthcare
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Luminex Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. PerkinElmer Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Waters Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Illumina, Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Eurofins Scientific
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. QIAGEN Bioinformatics
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Creative Proteomics
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Promega Corporation
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Sengenics
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Biomax Informatics AG
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. MS Bioworks LLC
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
        19. WuXi NextCODE
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Fios Genomics Ltd.
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients